CTT Pharmaceutical (CTTH) CEO Buys 3,000 Shares

What Happened
The company's CEO (individual name not specified in the provided filing summary) made a purchase of 3,000 shares of CTT Pharmaceutical Holdings, Inc. (CTTH) on September 2, 2026. The shares were acquired at $0.05 per share for a total transaction value of approximately $147. This was a purchase (transaction code P), which is generally a more informative signal than a sale, though the dollar amount is very small.

Key Details

• Transaction date: 2026-09-02
• Transaction type: Purchase (open market or private purchase; code P)
• Shares acquired: 3,000 at $0.05 per share
• Total value: ~$147
• Shares owned after transaction: Not disclosed in the provided summary
• Filing timeliness: Filing date matches the transaction date provided; no late filing indicated in the summary

Context
Purchases by insiders can signal confidence, but this trade is very small in dollar terms, so it provides limited insight into the CEO's overall view. No additional notes (e.g., 10b5-1 plan, tax withholding, or cashless exercise) were provided in the summary. Retail investors should consider this alongside other insider activity and company fundamentals.